MZOClass II
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
21 CFR 866.3169 / Microbiology
MZO is the FDA product code for Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus, a class II device type, regulated under 21 CFR 866.3169. As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and 7 recalls.
Classification record
- Product code
- MZO
- Device name
- Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
- Regulation
- 21 CFR 866.3169
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 3
- Ingested recalls
- 7
Clearances, product code MZO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2023 | 1 |
| 2026 | 2 |
Applicants with the most clearances
Product code MZO| Applicant | Clearances |
|---|---|
| Abbott Laboratories | 1 |
| Abbott Medical | 1 |
| Roche Diagnostics GmbH | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Medical
- CBR Enterprise Limited
- CTK Biotech, Inc.
- Diafarma Ecza Deposu ve Medikal Dis Ticaret Dis Tic Ltd Sti
- Diagnostic Automation/ Cortez Diagnostics Inc.
- DiaSorin Italia S.p.A UK Branch
- DiaSorin Italia S.p.A.
- OraSure Technologies, Inc.
- Ortho-Clinical Diagnostics European Support Center
- Ortho-Clinical Diagnostics, Inc.
- Roche Diagnostics GmbH
- Sanicure BV
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
